SCHEMBL4470018

SCHEMBL4470018

Fc1ccccc1C(Cl)(Cl)c1ccccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 5/20 0.41
ACHE P22303 1/20 0.38
KCNE1 P15382 1/20 0.36
KCNQ1 P51787 1/20 0.36
NFE2L2 Q16236 2/20 0.36
ALDH1A1 P00352 1/20 0.36
ALOX15 P16050 1/20 0.36
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
KIF11 P52732 1/20 0.33
TSHR P16473 1/20 0.33
SLC22A12 Q96S37 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32
MLNR O43193 1/20 0.32
NR1I2 O75469 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
TBXA2R P21731 1/20 0.32
CCKBR P32239 1/20 0.32
OPRK1 P41145 1/20 0.32
SLC6A3 Q01959 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11865649 0.89 KCNN4 (0.41) KCNN4ACHEKCNE1KCNQ1NFE2L2
SCHEMBL11868726 0.87 ACHE (0.50) KCNN4ACHEKCNE1KCNQ1ALDH1A1
SCHEMBL11861229 0.85 KCNN4 (0.48) KCNN4ACHEKCNE1KCNQ1ALDH1A1
SCHEMBL5720357 0.83 KCNN4 (0.41) KCNN4ACHEKCNE1KCNQ1NFE2L2
SCHEMBL30211828 0.83 KCNN4 (0.41) KCNN4ACHEKCNE1KCNQ1NFE2L2
SCHEMBL11862432 0.82 KCNN4 (0.51) KCNN4KCNE1KCNQ1NFE2L2KIF11
SCHEMBL5668721 0.81 KCNN4 (0.39) KCNN4ACHEKCNE1KCNQ1NFE2L2
SCHEMBL11870677 0.80 TSHR (0.38) KCNN4NFE2L2ALDH1A1TSHR
SCHEMBL3206408 0.80 CYP3A4 (0.52) NFE2L2TSHR
SCHEMBL11864594 0.80 NFE2L2 (0.39) KCNN4KCNE1KCNQ1NFE2L2KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7576088-B2 Benzodioxole derivatives HOFFMAN-LA ROCHE INC. (US) 2009-08-18 US disclosed
EP-1532132-B1 NOVEL BENZODIOXOLES HOFFMANN LA ROCHE (CH) 2008-03-19 EP disclosed
US-20050143373-A1 Benzodioxole derivatives ALANINE ALEXANDER (FR) 2005-06-30 US disclosed
US-6900227-B2 Benzodioxole derivatives HOFFMANN-LA ROCHE INC. (US) 2005-05-31 US disclosed
EP-1532132-A1 NOVEL BENZODIOXOLES F.HOFFMANN-LA ROCHE AG (CH) 2005-05-25 EP disclosed
US-20040142922-A1 Benzodioxole derivatives HOFFMANN-LA ROCHE INC. 2004-07-22 US disclosed
WO-2004013120-A1 NOVEL BENZODIOXOLES F. HOFFMANN-LA ROCHE AG (CH) 2004-02-12 WO disclosed
US-6632949-B2 Difluoro-diamine methylene derivatives MITSUI CHEMICALS, INC. (JP) 2003-10-14 US disclosed
US-20030004348-A1 Halogenating agents SONODA HIROSHI (JP) 2003-01-02 US disclosed
US-3985766-A ANTIMYCOTICS BAYER AKTIENGESELLSCHAFT (DT) 1976-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143373-A1 Benzodioxole derivatives CNR2, CNR1, GPR119 KCNN4 1843/4885ACHE 3827/4885KCNE1 1866/4885
US-20030004348-A1 Halogenating agents AFF1, NAF1, AFF2 KCNN4 2361/4885ACHE 4429/4885KCNE1 1406/4885
US-20040142922-A1 Benzodioxole derivatives CNR1, CNR2, GPR119 KCNN4 1690/4885ACHE 4242/4885KCNE1 1390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.